Job Watch

Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed)

Funding Opportunity PA-20-047 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) to develop and validate next-generation single cell analysis technologies and tools. The purpose is to foster the commercialization of innovative single cell analysis technologies for their broad use in biomedical research. The novel single-cell analysis technologies will aid in obtaining a fine-grained and dynamic view of heterogeneous cellular states and intercellular interactions, thereby providing new mechanistic insight into biological processes in health and disease. Applications should define the current state of technologies and tools as a benchmark against which the new approach(es) will be measured. The new approach(es) should provide substantially improved performance in sensitivity, selectivity, spatiotemporal resolution, scalability, multiplexing capability, or non-destructive analysis of molecular or functional measures of single cells. A companion FOA to support STTR Grants is also available see PA-xx-XXX.

Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed)

Funding Opportunity PA-20-025 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer Research (STTR) grant applications from small business concerns (SBCs) to develop and validate next-generation single cell analysis technologies and tools. The purpose is to foster the commercialization of innovative single cell analysis technologies for their broad use in biomedical research. The novel single-cell analysis technologies will aid in obtaining a fine-grained and dynamic view of heterogeneous cellular states and intercellular interactions, thereby providing new mechanistic insight into biological processes in health and disease. Applications should define the current state of technologies and tools as a benchmark against which the new approach(es) will be measured. The new approach(es) should provide substantially improved performance in sensitivity, selectivity, spatiotemporal resolution, scalability, multiplexing capability, or non-destructive analysis of molecular or functional measures of single cells.

CK Group: Senior Bioinformatistician

New Scientist - Bioinformatics - Mon, 2020-01-06 19:00
Competitive: CK Group: Emily Mills at CK Technical is recruiting for a Senior Bioinformatistician to join a clinical stage, biopharmaceutical company at their site based in Cambridge on... Cambridge
Categories: Job Watch

F. Hoffmann-La Roche AG: (Principal / Senior) or Biomedical Data Standards Specialist - Controlled Terminology

New Scientist - Bioinformatics - Mon, 2020-01-06 12:42
F. Hoffmann-La Roche AG: Data have the power to answer more than one question and enable multiple discoveries, but only if Findable, Accessible, Interoperable, and Reusable ( Switzerland (CH)
Categories: Job Watch

F. Hoffmann-La Roche AG: (Principal / Senior) or Biomedical Data Standards Specialist - Data Collection

New Scientist - Bioinformatics - Mon, 2020-01-06 12:39
F. Hoffmann-La Roche AG: Data have the power to answer more than one question and enable multiple discoveries, but only if Findable, Accessible, Interoperable, and Reusable ( Switzerland (CH)
Categories: Job Watch

Notice of Special Interest (NOSI): Biomarkers and Biotypes of Drug Addiction

Notice NOT-DA-20-012 from the NIH Guide for Grants and Contracts

SRG: Field Application Scientist

New Scientist - Bioinformatics - Mon, 2020-01-06 06:07
Negotiable: SRG: Field Application Scientist (FAS) South Cambridgeshire UK based travel Cambridge, England
Categories: Job Watch

Biomarker Data Specialist II - Seattle Genetics, Inc. - Bothell, WA

Indeed.com - Bioinformatics - Fri, 2020-01-03 19:17
Internal stakeholders may include Clinical Pharmacologists, Biomarker & Bioinformatics scientists, Clinical Project Managers and others.
From Seattle Genetics, Inc. - Sat, 04 Jan 2020 00:17:00 GMT - View all Bothell, WA jobs
Categories: Job Watch

F. Hoffmann-La Roche AG: (Principal / Senior) or Biomedical Data Standards Specialist - Controlled Terminology

New Scientist - Bioinformatics - Fri, 2020-01-03 12:41
F. Hoffmann-La Roche AG: Data have the power to answer more than one question and enable multiple discoveries, but only if Findable, Accessible, Interoperable, and Reus Switzerland (CH)
Categories: Job Watch

Pages

Subscribe to Anil Jegga aggregator - Job Watch